Riskpilot← Back to searchSign inGet full accessWasa Medicals Sweden AB
ABActiveOrg 5569861213Schélevägen 1Manufacture of other food products n.e.c. · NACE 1089Est. 20141 employees
Revenue 2025
SEK 634K
+22% vs 2024
EBITDA margin
-61.1%
+30% vs 2024
Equity ratio
47.7%
Financial strength
Net profit 2025
SEK -38K
-2577% vs 2024
| Revenue | SEK 634K | +22% |
| EBITDA | SEK -387K | +30% |
| Net profit | SEK -38K | -2577% |
| Total assets | SEK 230K | -39% |
| Equity | SEK 110K | -26% |
| Employees | 1 | — |
Legal name
Wasa Medicals Sweden AB
Org number
5569861213
Legal form
Aktiebolag
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
14 oktober 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Cedgård, Katarzyna Magdalena Cedgård, Per Lennart
Company purpose
Aktiebolaget ska bedriva tillverkning av kosttillskott, farmaceutiska, functional food, läkemedel och bedriva medicinsk konsultationsverksamhet samt därmed förenlig verksamhet.
Address
Schélevägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 770 | 741 | 839 | 518 | 634 |
| Staff expenses | — | −673 | −651 | −669 | −589 |
| EBITDA | −204 | −313 | −229 | −553 | −387 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −204 | −313 | −229 | −553 | −387 |
| Net financials | −48 | −1 | −0 | — | −0 |
| Profit before tax | 48 | 37 | 21 | 2 | −38 |
| Tax | −10 | 2 | −4 | −0 | — |
| Net profit | 38 | 38 | 16 | 2 | −38 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 369 | 345 | 350 | 377 | 230 |
| Equity | 91 | 129 | 146 | 147 | 110 |
| Long-term debt | 0 | 0 | 13 | 17 | 16 |
| Short-term debt | 278 | 215 | 191 | 213 | 104 |
| Total debt | 278 | 215 | 204 | 229 | 120 |
EBITDA margin
-61.1%
This company
15.8%
Market median
-487% vs market
20212025
Equity ratio
47.7%
This company
38.2%
Market median
+25% vs market
20212025
Return on equity
-34.5%
This company
18.4%
Market median
-288% vs market
20212025
Net profit margin
-6.0%
This company
8.1%
Market median
-174% vs market
20212025
Asset turnover
2.76×
This company
1.12×
Market median
+146% vs market
20212025
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
ML | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 91% | 91% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Wasa Medicals AB
Wasa Medicals Sweden AB Board members of Wasa Medicals Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats-Åke Lennart Andersson | Audit | 0 companies |
| Per Lennart Cedgård | Chairman | 0 companies |
| Katarzyna Magdalena Cedgård | Deputy Board Member | 0 companies |
| Ingela Ann-Margreth Brabäck | Deputy Board Member | 0 companies |
| Pär Thomas Trotzig | Board of Directors | 0 companies |